Skip to content
Back to Investors
Oxford Capital

Oxford Capital

Venture Capital

Oxford Capital is a specialist investment manager focused on high-potential investments in early and growth stage UK technology companies.


Recent investments

Seed
£1.1M

Aviva Ventures led the seed financing round for the London-based healthtech firm, with participation from Ascension, Oxford Capital, and Cur8 Capital.

"So far, we’ve been driven by a singular mission to unlock and simplify access to everything you need to live a healthier life, which requires a shift in how health and well-being services are provided and paid for, and means putting the user in the driver seat and giving them more control. By creating an integrated network of health providers and payers, we can improve access to personalised health services, particularly in traditionally underfunded and underserved areas, such as early diagnosis, women’s health, mental health and neurodiversity."
— David Joerring, Co-Founder and CEO
Series A
£9.7M

The investment round was co-led by Aviva Ventures, YZR Capital, Oxford Capital, Triple Point Ventures and Simplyhealth Ventures to fund US expansion and new product development.

"Our investment in Scan.com is a statement of our intent to invest in promising young digital and tech firms – they are growing rapidly, have a unique customer proposition and are already leading the way on medical imaging services in the UK. We are really excited to support Scan.com’s development and growth."
— Ben Luckett, Chief Innovation Officer
Series B
$46.0M

The round was led by 2150 and Energy Impact Partners alongside Legal & General Capital.

"This funding round and acquisition of BeWarm marks a significant new chapter for Hometree, enabling us to deliver on our long-held vision of building the leading residential energy efficiency platform across Europe. The recent energy crisis has shown that we can’t remain reliant on foreign gas to heat and power our homes, and Hometree has a key role to play in helping homeowners transition to a more safe, stable and affordable energy system."
— Simon Phelan, CEO
Series B
$20.0M

Octopus Ventures led the series B round, which will help the digital therapeutics platform grow its footprint across the UK and Europe.

"HelloSelf is about giving everyone access to the personalised psychological advice they need. We want to help make Every Self Better. I’m delighted that Octopus has joined the mission. There are over 1.2Bn people who are underserved globally so with this investment and the trust of our network we can accelerate HelloSelf’s impact across the UK and beyond."
— Charlie Wells, Founder
Seed
£3.0M

Parkwalk Advisors led the financing round, which will support UK sales growth and international expansion plans.

"For scaling companies, keeping track of terms across hundreds or thousands of contracts is a challenge that creeps up on you. Searching for basic information like contract start and end dates, or nuances in confidentiality terms across entire databases of contracts is painfully manual, or impossible. Before working with us, we know that some of our customers would spend weeks doing this"
— Charles Brecque, Founder and CEO